Safety and Efficacy of Amiodarone in a Patient With COVID-19

There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19). Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis and viral replication. Here, to our knowledge, we report the first case of a patient affected by respiratory failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Castaldo, Nadia, Aimo, Alberto, Castiglione, Vincenzo, Padalino, Cristiano, Emdin, Michele, Tascini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
First Reported
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259916/
https://www.ncbi.nlm.nih.gov/pubmed/32835273
http://dx.doi.org/10.1016/j.jaccas.2020.04.053
Descripción
Sumario:There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19). Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis and viral replication. Here, to our knowledge, we report the first case of a patient affected by respiratory failure related to COVID-19 who recovered after only supportive measures and a short amiodarone course. (Level of Difficulty: Beginner.)

Ejemplares similares